Search
Search Results
##search.searchResults.foundPlural##
-
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1576PDF: 604HTML: 190 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4493PDF: 1920HTML: 17736 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1602PDF: 798HTML: 1232Figure 1: 172Figure 2: 188Figure 3: 183 -
-
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1064PDF: 1065HTML: 442 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4785PDF: 1897HTML: 11044Fig 1: 222Fig 2: 183Fig 3: 301Fig 4: 187Fig 5: 179Fig 6: 174Fig 7: 188Fig 8: 182 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1773PDF: 938HTML: 1111Untitled: 152Untitled: 170Untitled: 157Untitled: 158 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2923PDF: 1021HTML: 4583 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
326PDF: 264Suppl. Files: 46HTML: 12 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1750PDF: 531HTML: 16970Figure 4: 166Figure 3: 140Figure 2: 145Figure 1: 177 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3920Suppl. Files: 1115PDF: 1066Html: 176 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3261PDF: 1091HTML: 437 -
WHAT ARE FUNGAL INFECTIONS?
4185PDF: 2381HTML: 27594de Pauw: 235 -
-
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1660PDF: 645HTML: 2431 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
972PDF: 533HTML: 722 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4756PDF: 2836HTML: 2284 -
-
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1998PDF: 1133HTML: 626 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4300PDF: 1372HTML: 2039 -
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
5305PDF: 2646HTML: 49577 -
-
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2688PDF: 765HTML: 219 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1101PDF: 543HTML: 1690Figures: 167Fifures Sanz: 176tables Sanz: 180Untitled: 176







